Recombinant SARS-CoV-2 Envelope Protein, Avi and His Tag
Figure-1:Recombinant 2019-nCoV envelope Protein was determined by SDS-PAGE with Coomassie Blue, showing a band at 12 kDa.
Roll over image to zoom in
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
| Amount : | 100 μg |
| Purification : | >95% by SDS-PAGE. |
| Content : | Supplied as a 0.22 μm filtered solution in 20mM Tris,250mM NaCl,0.5%TritonX-100,pH 8.0. |
| Storage condition : | This product is stable at ≤-70°C for up to 6 months from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature.Avoid repeated freeze-thaw cycles. |
| AA sequence : | Recombinant 2019-nCoV envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of 2019-ncov envelope fused with a 6×His,Avi tag at the N-terminus. |
| Gene ID : | 43740570 |
| Alternative Name : | 2019-nCoV E protein;2019-nCoV sM protein;Envelope protein;Env polyprotein;Envelope glycoprotein;env;COVID-19 |
Source: E. coli. Recombinant 2019-nCoV envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of 2019-ncov envelope fused with a 6×His,Avi tag at the N-terminus.
Endotoxin : < 1.0 EU/μg of the protein by LAL method.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
DÃez JM, Romero C, Cruz M, Vandeberg P, Merritt WK, Pradenas E, Trinité B, Blanco J, Clotet B, Willis T, Gajardo R.
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.
J Infect Dis. 2022 Mar 15;225(6):938-946. doi: 10.1093/infdis/jiab540.
PMID: 34693968; PMCID: PMC8574314.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
